X-Linked Hypophosphatemia Latest Advances
Find the Latest Research About X-Linked Hypophosphatemia
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3057 publications
Authors' Reply: Creatinine-Normalized Phosphaturia after Phosphate Loading in Skeletal Muscle-Specific Fgf23 Knockout Mice.
Journal: Journal of the American Society of Nephrology : JASN
Published: March 13, 2026
Creatinine-Normalized Phosphaturia after Phosphate Loading in Skeletal Muscle-Specific Fgf23 Knockout Mice.
Journal: Journal of the American Society of Nephrology : JASN
Published: March 13, 2026
X-linked hypophosphatemic rickets: a rare case report.
Journal: Acta orthopaedica Belgica
Published: March 02, 2026
Transition of Care in X-Linked Hypophosphatemic Rickets: From Pediatric to Adult Practice- A Narrative Review.
Journal: Journal of clinical research in pediatric endocrinology
Published: February 19, 2026
Current advances of bone homeostasis imbalance in the cause of hereditary metabolic bone diseases.
Journal: EFORT open reviews
Published: February 04, 2026
A Japanese Patient With Craniosynostosis Due to X-Linked Hypophosphatemic Rickets Who Underwent Fronto-Orbital Distraction.
Journal: The Journal of craniofacial surgery
Published: February 02, 2026
Hypophosphatemic Osteomalacia Induced by Low-Dose Adefovir-Related Fanconi Syndrome.
Journal: Journal of medical cases
Published: January 09, 2026
Tenofovir-Associated Hypophosphatemic Osteomalacia in an HIV-Infected Patient: A Case Report.
Journal: Cureus
Published: January 07, 2026
Phenotypic Diversity in Autosomal Recessive Hypophosphatemic Rickets Type 2.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: January 06, 2026
Case Report: A case of x-linked hypophosphatemic rickets complicated with polyostotic fibrous dysplasia caused by PHEX gene mutation and literature review.
Journal: Frontiers in endocrinology
Published: January 05, 2026
A phase 2 trial of burosumab for treatment of fibroblast growth factor-23 mediated hypophosphatemia in children and adults with fibrous dysplasia.
Journal: medRxiv : the preprint server for health sciences
Published: January 02, 2026
Last Updated: 04/28/2026